TG Therapeutics
TGTX
$18.61
Share price
-3.02%
Change (1 day)
-18.63%
Change (1 year)
Categories
P/S ratio for TG Therapeutics (TGTX)
P/S ratio as of June 2024 (TTM): 10.3
According to TG Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 10.25. At the end of 2023 the company had a P/S ratio of 11.1.
P/S ratio history for TG Therapeutics from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 11.1 | -98.21% |
| 2022 | 618 | 52.11% |
| 2021 | 406 | -99.14% |
| 2020 | > 1000 | 490.44% |
| 2019 | > 1000 | 253.09% |
| 2018 | > 1000 | -40.61% |
| 2017 | > 1000 | 128.07% |
| 2016 | > 1000 | -60.53% |
| 2015 | > 1000 | -9.4% |
| 2014 | > 1000 | 432.14% |
| 2013 | 878 | -82.21% |
| 2012 | > 1000 | |
| 2011 | N/A | |
| 2010 | N/A | |
| 2009 | N/A | |
| 2002 | 2.04 | 111.56% |
| 2001 | 0.9636 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Alkermes ALKS | 2.37 | -76.87% | 🇮🇪 Ireland |
 Dr. Reddy's RDY | 3.58 | -65.09% | 🇮🇳 India |